News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Continue Reading Previous Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Brain Clinical Trial Healthcare News Pharmaceutical Pregnancy Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients Staff November 23, 2024 Healthcare Hospitals News Nursing Patient Care Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring Staff November 23, 2024 Apps Financial Fitness News Nutrition Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends – Technavio Staff November 23, 2024
